MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
162 hedge funds and large institutions have $873M invested in Momenta Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 64 increasing their positions, 49 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
162
Holders Change
+2
Holders Change %
+1.25%
% of All Funds
4.04%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
25
Increased
64
Reduced
49
Closed
18
Calls
$1.54M
Puts
$329K
Net Calls
+$1.21M
Net Calls Change
-$493K
Top Buyers
| 1 |
BlackRock
New York
|
+$117M |
| 2 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$12.3M |
| 3 |
State Street
Boston,
Massachusetts
|
+$7.71M |
| 4 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
+$5.75M |
| 5 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
+$5.61M |
Top Sellers
| 1 |
DCM
Discovery Capital Management
South Norwalk,
Connecticut
|
-$19.3M |
| 2 |
Millennium Management
New York
|
-$15M |
| 3 |
O
OrbiMed
New York
|
-$11.3M |
| 4 |
SC
Samlyn Capital
New York
|
-$3.97M |
| 5 |
SAM
Senzar Asset Management
New York
|
-$2.92M |
